Clinicopathological Characteristics and Outcomes of Chinese Patients with Scanty Immune Deposits Lupus Nephritis: A Large Cohort Study from a Single Center

被引:3
作者
Li, Qiuyu [1 ,2 ,3 ,4 ]
Song, Di [1 ,2 ,3 ,4 ]
Wang, Fengmei [1 ,2 ,3 ,4 ]
Tan, Ying [1 ,2 ,3 ,4 ]
Yu, Feng [1 ,2 ,3 ,4 ]
Zhao, Minghui [1 ,2 ,3 ,4 ]
机构
[1] Peking Univ, Hosp 1, Dept Med, Div Renal, Beijing 100034, Peoples R China
[2] Peking Univ, Inst Nephrol, Beijing 100034, Peoples R China
[3] Minist Hlth China, Key Lab Renal Dis, Beijing 100034, Peoples R China
[4] Minist Educ, Key Lab Chron Kidney Dis Prevent & Treatment, Beijing 100034, Peoples R China
来源
SCIENTIFIC WORLD JOURNAL | 2014年
基金
中国国家自然科学基金;
关键词
ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES; ALTERNATIVE COMPLEMENT PATHWAY; DISEASE-ACTIVITY; PAUCI-IMMUNE; C4B-BINDING PROTEIN; INTRAVENOUS CYCLOPHOSPHAMIDE; MYCOPHENOLATE-MOFETIL; ACTIVATION PRODUCTS; ERYTHEMATOSUS; GLOMERULONEPHRITIS;
D O I
10.1155/2014/212597
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objective. To assess clinicopathological characteristics of lupus nephritis patients with scanty immune deposits. Methods. The data of patients with scanty immune deposits lupus nephritis were retrospectively analyzed. Plasma ANCA and complement components were detected. Results. Among 316 cases with renal biopsy-proven lupus nephritis, 40 cases were diagnosed as scanty immune deposits. There were significantly higher value of serum creatinine (P = 0.002) and lower hemoglobin level (P = 0.009) and higher score of cellular crescents (P = 0.015) in scanty immune deposits group compared with immune complex deposits group. The frequency of positive plasma ANCA was significantly higher in scanty immune deposits group than that in immune complex deposits group (52.5% versus 10.1%, P < 0.001). As for comparisons of plasma complement components, there were significantly higher levels of C1q (P = 0.005) and Bb (P = 0.02) and lower level of factor H (P = 0.003) in scanty immune deposits group. The ratio of treatment failure was significantly higher in scanty immune deposits group than that in immune deposits group (42.5% versus 19.20%, P = 0.001). The renal outcomes were similar between the two groups. Conclusions. Patients with scanty immune deposits lupus nephritis had more severe kidney damage. ANCA and activation of complement alternative pathway might be involved in the pathogenesis of the disease.
引用
收藏
页数:11
相关论文
共 43 条
  • [1] Abdellatif AA, 2010, CLIN NEPHROL, V74, P106
  • [2] APPEL GB, 1994, J AM SOC NEPHROL, V4, P1499
  • [3] PREDICTING RENAL OUTCOMES IN SEVERE LUPUS NEPHRITIS - CONTRIBUTIONS OF CLINICAL AND HISTOLOGIC DATA
    AUSTIN, HA
    BOUMPAS, DT
    VAUGHAN, EM
    BALOW, JE
    [J]. KIDNEY INTERNATIONAL, 1994, 45 (02) : 544 - 550
  • [4] AUSTIN HA, 1984, KIDNEY INT, V25, P689, DOI 10.1038/ki.1984.75
  • [5] Complement Factor H Deficiency Accelerates Development of Lupus Nephritis
    Bao, Lihua
    Haas, Mark
    Quigg, Richard J.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 22 (02): : 285 - 295
  • [6] C4B-BINDING PROTEIN, A REGULATORY COMPONENT OF THE CLASSICAL PATHWAY OF COMPLEMENT, IS AN ACUTE-PHASE PROTEIN AND IS ELEVATED IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    BARNUM, SR
    DAHLBACK, B
    [J]. COMPLEMENT AND INFLAMMATION, 1990, 7 (02) : 71 - 77
  • [7] CCP1-4 of the C4b-binding protein α-chain are required for factor I mediated cleavage of complement factor C3b
    Blom, AM
    Kask, L
    Dahlbäck, B
    [J]. MOLECULAR IMMUNOLOGY, 2003, 39 (10) : 547 - 556
  • [8] DERIVATION OF THE SLEDAI - A DISEASE-ACTIVITY INDEX FOR LUPUS PATIENTS
    BOMBARDIER, C
    GLADMAN, DD
    UROWITZ, MB
    CARON, D
    CHANG, CH
    [J]. ARTHRITIS AND RHEUMATISM, 1992, 35 (06): : 630 - 640
  • [9] ACTIVATION OF THE ALTERNATIVE COMPLEMENT PATHWAY ACCOMPANIES DISEASE FLARES IN SYSTEMIC LUPUS-ERYTHEMATOSUS DURING PREGNANCY
    BUYON, JP
    TAMERIUS, J
    ORDORICA, S
    YOUNG, B
    ABRAMSON, SB
    [J]. ARTHRITIS AND RHEUMATISM, 1992, 35 (01): : 55 - 61
  • [10] ASSESSMENT OF DISEASE-ACTIVITY AND IMPENDING FLARE IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS - COMPARISON OF THE USE OF COMPLEMENT SPLIT PRODUCTS AND CONVENTIONAL MEASUREMENTS OF COMPLEMENT
    BUYON, JP
    TAMERIUS, J
    BELMONT, HM
    ABRAMSON, SB
    [J]. ARTHRITIS AND RHEUMATISM, 1992, 35 (09): : 1028 - 1037